Findings from INSERM advance knowledge in colon cancer
2008 JAN 17 -- "Several genes have been recognized, when mutated in the germline, to highly predispose to colorectal cancer, impairing the DNA mismatch repair system in hereditary nonpolyposis colon cancer syndrome, or APC/MYH in adenomatous polyposis. However, 10 percent of microsatellite stable colorectal cancer is reported to develop in an unexplained context of genetic predisposition," investigators in Marseille, France report. "This study was designed to depict the genetic mechanisms underlying early-onset microsatellite stable colon cancers. Patients younger than aged 50 years undergoing primary surgical resection for colon carcinoma were collected prospectively between 1993 and 2003. A first series of 8 samples has been allelotyped using 361 poly-CA polymorphisms distributed on the 39 autosomal arms within a larger set of 166 sporadic tumors. Genotyping of 24 poly-CA polymorphisms distributed on the 8 chromosomes exhibiting allelic losses in more than 30 percent of the previous cases was then applied to an independent series of 40 tumors. A third series of 70 tumors has been genotyped on chromosome 14 only. Comparison of genomic profile from patients younger and older than aged 50 years at the 8 most frequently lost chromosomes allowed, identify chromosome 14 as showing a significant difference between the two groups. Dense chromosome 14 genotyping detected two partial deletions in a general background of 57 percent allelic loss, pointing at a region located between D14S63 and D14S292. These observations suggest that a tumor-suppressor gene located on chromosome 14 might have an important role in microsatellite stable colon carcinogenesis," wrote N. Mourra and colleagues, INSERM. The researchers concluded: "Because it seems to be more frequently involved in early-onset cases, it could be a good candidate in inherited conditions." Mourra and colleagues published their study in Diseases of the Colon & Rectum (High frequency of chromosome 14 deletion in early-onset colon cancer. Diseases of the Colon & Rectum, 2007;50(11):1881-1886). For additional information, contact S. Olschwang, Institute J Paoli I Calmettes, INSERM, UMR599, 232 Blvd. Sainte Marguerite, F-13009 Marseille, France. The publisher of the journal Diseases of the Colon & Rectum can be contacted at: Springer, 233 Spring Street, New York, NY 10013, USA. Keywords: France, Marseille, Adenomatous Polyp, Biotechnology, Colon Cancer, Colon Carcinoma, Colorectal, DNA, Endocrinology, Gastroenterology, Gene Therapy, Genetics, Genomics, Oncology, INSERM. This article was prepared by Gene Therapy Weekly editors from staff and other reports. Copyright 2008, Gene Therapy Weekly via NewsRx.com.
|
